Motivational Factors to Receive the COVID-19 Vaccine in the United Arab Emirates: A Cross-Sectional Study
Overview
Authors
Affiliations
The United Arab Emirates has been very successful in its vaccination campaign for the COVID-19 injection, and vaccine hesitancy is not currently a major concern. Nevertheless, the motivations of residents in the UAE to receive the COVID-19 vaccine are varied. In this study with 426 vaccinated participants, 55% expressed health motivations to receive the vaccine, whereas 45% expressed non-health motivations. Nationality was a predictive factor in motivation, as expatriates from South Asian countries expressed the lowest motivation to get the vaccine on the basis of intrinsic health reasons, followed by expatriates from Arab countries, Emiratis, and expatriates from the rest of the world. The same nationality pattern was observed in vaccine readiness and vaccine knowledge. Both of these variables had a correlation with intrinsic health motivation in receiving the vaccine. No significant difference across nationalities was observed regarding vaccine conspiracy beliefs, and this variable only had a weak negative correlation with motivations to receive the vaccine.
Andrade G, Abdelmonem K, Teir H, AlQaderi N, Elamin A, Bedewy D BMC Psychol. 2025; 13(1):138.
PMID: 39972498 PMC: 11841263. DOI: 10.1186/s40359-025-02456-y.
Bouaddi O, Seedat F, Hasaan Mohammed H, Evangelidou S, Deal A, Requena-Mendez A EClinicalMedicine. 2024; 78:102950.
PMID: 39687424 PMC: 11647140. DOI: 10.1016/j.eclinm.2024.102950.
Andrade G, Abdelmonem K, AlQaderi N, Teir H, Elamin A, Bedewy D SAGE Open Nurs. 2024; 10:23779608241261622.
PMID: 38881678 PMC: 11177738. DOI: 10.1177/23779608241261622.
Zhang X, Du L, Huang Y, Luo X, Wang F BMC Public Health. 2024; 24(1):316.
PMID: 38287265 PMC: 10823630. DOI: 10.1186/s12889-024-17770-0.
Estimation of cutoff score for the 7C of vaccination readiness scale.
Machida M, Takamiya T, Odagiri Y, Fukushima N, Kikuchi H, Inoue S Vaccine X. 2023; 15:100394.
PMID: 37808267 PMC: 10550591. DOI: 10.1016/j.jvacx.2023.100394.